Reaction Details Report a problem with these data
Target
Mitogen-activated protein kinase kinase kinase 8 [30-404]
Ligand
BDBM225230
Substrate
n/a
Meas. Tech.
HMT Assay
IC50
>1.0e+4±n/a nM
Citation
Qi, W; Zhao, K; Gu, J; Huang, Y; Wang, Y; Zhang, H; Zhang, M; Zhang, J; Yu, Z; Li, L; Teng, L; Chuai, S; Zhang, C; Zhao, M; Chan, H; Chen, Z; Fang, D; Fei, Q; Feng, L; Feng, L; Gao, Y; Ge, H; Ge, X; Li, G; Lingel, A; Lin, Y; Liu, Y; Luo, F; Shi, M; Wang, L; Wang, Z; Yu, Y; Zeng, J; Zeng, C; Zhang, L; Zhang, Q; Zhou, S; Oyang, C; Atadja, P; Li, E An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED. Nat Chem Biol 13:381-388 (2017) [PubMed] Article
More Info.:
Target
Name:
Mitogen-activated protein kinase kinase kinase 8 [30-404]
Synonyms:
COT | ESTF | M3K8_HUMAN | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 (MAP3K8)
Type:
Protein
Mol. Mass.:
42506.70
Organism:
Homo sapiens (Human)
Description:
Human MAP3K8 truncation (30-404 aa)
Residue:
375
Sequence:
MENLYASEEPAVYEPSLMTMCQDSNQNDERSKSLLLSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGRYQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVEIQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKGLDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVILCRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPGMRELIEASLERNPNHRPRAADLLKHEALNPPREDQPRCQSLDSA